Viral load and short-term natural history of type-specific oncogenic human papillomavirus infections in a high-risk cohort of midadult women
Authors:
Open Access
- 6 October 2013
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 134 (8) , 1889-1898
Abstract
Oncogenic human papillomavirus (HPV) viral load may inform the origin of newly detected infections and characterize oncogenic HPV natural history in midadult women. From 2007 to 2011, we enrolled 521 25–65‐year‐old‐female online daters and followed them triannually with mailed health and sexual behavior questionnaires and kits for self‐sampling for PCR‐based HPV DNA testing. Samples from oncogenic HPV positive women were selected for type‐specific DNA load testing by real‐time PCR with adjustment for cellularity. Linear or logistic regression models were used to evaluate relationships between viral levels, health and sexual behavior, and longitudinal oncogenic HPV detection. Type‐specific viral levels were borderline significantly higher in oncogenic HPV infections that were prevalent versus newly detected (p = 0.092), but levels in newly detected infections were higher than in infections redetected after intercurrent negativity (p < 0.001). Recent sex partners were not significantly associated with viral levels. Compared with prevalent infections detected intermittently, the likelihood of persistent (OR = 4.31, 95% CI: 2.20–8.45) or single‐time (OR = 1.32, 95% CI: 1.03–1.71) detection increased per 1‐unit increase in baseline log10 viral load. Viral load differences between redetected and newly detected infections suggest a portion of new detections were due to new acquisition, although report of recent new sex partners (a potential marker of new infection) was not predictive of viral load; oncogenic HPV infections in midadult women with new partners likely represent a mix of new acquisition and reactivation or intermittent detection of previous infection. Intermittent detection was characterized by low viral levels, suggesting that intermittent detection of persisting oncogenic HPV infection may be of limited clinical significance.Keywords
Funding Information
- National Institutes of Health (K01 AI 079270, U19 AI 31448)
This publication has 50 references indexed in Scilit:
- Type-specific persistence and associated risk factors of human papillomavirus infections in women living in central ItalyEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2013
- Evidence and Impact of Human Papillomavirus LatencyThe Open Virology Journal, 2012
- Human Papillomavirus Persistence in Young Unscreened Women, a Prospective Cohort StudyPLOS ONE, 2011
- Viral Load in the Natural History of Human Papillomavirus Type 16 Infection: A Nested Case–Control StudyThe Journal of Infectious Diseases, 2011
- Human Papillomavirus (HPV) Type 16 and Type 18 DNA Loads at Baseline and Persistence of Type‐Specific Infection during a 2‐Year Follow‐UpThe Journal of Infectious Diseases, 2009
- Persistence of HPV infection and risk of high-grade cervical intraepithelial neoplasia in a cohort of Colombian womenBritish Journal of Cancer, 2009
- Host and viral factors in relation to clearance of human papillomavirus infection: A cohort study in TaiwanInternational Journal of Cancer, 2008
- Clearance of oncogenic human papillomavirus (HPV) infection: effect of smoking (United States)Cancer Causes & Control, 2002
- Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control studyThe Lancet, 2000
- EFFECT OF CIGARETTE SMOKING ON CERVICAL EPITHELIAL IMMUNITY: A MECHANISM FOR NEOPLASTIC CHANGE?The Lancet, 1988